Abstract
Interleukin-2 (IL-2), originally described as a growth factor required for sustained proliferation of T cells in vitro1,2 is a glycoprotein hormone of known structure3 which appears to be important for the generation of immune responses in vivo4. As well as T lymphocytes, B lymphocytes5 and large granular lymphocytes with natural killer activity (NK cells)6 can also respond to IL-2. The action of IL-2 seemed to be limited specifically to lymphocytes, however, and the term 'T-lymphocytotrophic hormone' was used7. Here we provide evidence that human monocytes display a substantially increased cytotoxic activity as a direct and rapid response to human recombinant IL-2 but not to human recombinant glycosylated interferon-γ (IFN-γ) or lipopolysac-charide. Our results reveal a previously unknown function of IL-2 and suggest its possible involvement in monocyte-T cell interactions.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Morgan, D. A., Ruscetti, F. M. & Gallo, R. C. Science 193, 1007–1008 (1976).
Gillis, S. & Smith, K. A. Nature 268, 154–156 (1977).
Robb, R. J. Immun. Today 5, 203–209 (1984).
Malkovsky, M. & Medawar, P. B. Immun. Today 5, 340–343 (1984).
Waldmann, T. A. et al. J. exp. Med. 160, 1450–1466 (1984).
Ortaldo, J. R. et al. J. Immun. 133, 779–783 (1984).
Smith, K. A. A. Rev. Immun. 2, 319–333 (1984).
Yron, I., Wood, T. A., Spiess, P. J. & Rosenberg, S. A. J. Immun. 125, 238–245 (1980).
Grimm, E. A., Mazumder, A., Zhang, H. Z. & Rosenberg, S. A. J. exp. Med. 155, 1823–1841 (1982).
Grimm, E. A. et al. J. exp. Med. 157, 884–897 (1983).
Grimm, E. A. et al. J. exp. Med. 158, 1356–1361 (1983).
Rosenberg, S. A. et al. Science 223, 1412–1415 (1984).
Sondel, P. M. et al. J. Immun. 137, 502–511 (1986).
Malkovsky, M. et al. Proc. natn. Acad. Sci. U.S.A. 82, 536–538 (1985).
Hale, G. et al. Blood 62, 873–882 (1983).
Bubenik, J. et al. Neoplasma 24, 319–326 (1978).
Rinehart, J. J., Lange, P., Gormus, B. J. & Kaplan, M. E. Blood 52, 211–220 (1978).
Zanella, A. et al. J. immun. Meth. 41, 279–288 (1981).
Hildreth, J. E. K., Gotch, F. M., Hildreth, P. D. K. & McMichael, A. J. Eur. J. Immun. 13, 202–208 (1983).
Dongworth, D. W., Gotch, F. M., Hildreth, J. E. K., Morris, A. & McMichael, A. J. Eur. J. Immun. 15, 888–892 (1985).
Devos, R., Plaetinck, G. & Fiers, W. Eur. J. Immun. 14, 1057–1060 (1984).
Kelley, V. E., Fiers, W. & Strom, T. B. J. Immun. 132, 240–245 (1984).
Herrmann, F., Cannistra, S. A., Levine, H. & Griffin, J. D. J. exp. Med. 162, 1111–1116 (1985).
Benveniste, E. N. & Merrill, J. E. Nature 321, 610–613 (1986).
Devos, R. et al. Nucleic Acids Res. 11, 4307–4323 (1983).
Liang, S.-M. et al. Biochem. J. 229, 429–439 (1985).
Scahill, S. J., Devos, R., Van Der Heyden, J. & Fiers, W. Proc. natn. Acad. Sci. U.S.A. 80, 4654–4658 (1983).
Devos, R., Opsomer, C., Scahill, S. J., Van Der Heyden, J. & Fiers, W. J. Interferon Res. 4, 461–468 (1984).
Levin, J., Tomasulo, P. A. & Oser, R. S. J. Lab. clin. Med. 75, 903–911 (1970).
Malkovsky, M. et al. Proc. natn. Acad. Sci. U.S.A. 80, 6322–6326 (1983).
Malkovsky, M., Asherson, G. L., Stockinger, B. & Watkins, M. C. Nature 300, 652–655 (1982).
Malkovsky, M. et al. J. Immun. 130, 785–790 (1983).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Malkovský, M., Loveland, B., North, M. et al. Recombinant interleukin-2 directly augments the cytotoxicity of human monocytes. Nature 325, 262–265 (1987). https://doi.org/10.1038/325262a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/325262a0
This article is cited by
-
Fusion cytokine IL-2-GMCSF enhances anticancer immune responses through promoting cell–cell interactions
Journal of Translational Medicine (2016)
-
A phase I trial of immunotherapy with intratumoral adenovirus-interferon-gamma (TG1041) in patients with malignant melanoma
Cancer Gene Therapy (2003)
-
Different Roles of the CD2 and LFA-1 T-Cell Co-receptors for Regulating Cytotoxic, Proliferative, and Cytokine Responses of Human Vγ9/Vδ2 T Cells
Molecular Medicine (2000)
-
Progression mechanisms in colon cancer: soluble interleukin-2 (IL-2) receptor, IL-2 plus anti-CD3 proliferative response and tumour stage correlations
Cancer Immunology, Immunotherapy (1994)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.